Open an account

OSR Holdings

OSRH · NASDAQ

$0.2099−$0.0001 (−0.05%)TodayMarket closed ·
Prev close $0.21

About OSRH

OSR Holdings, Inc. operates as a global healthcare company. The company is headquartered in Bellevue, Washington and currently employs 22 full-time employees. The company went IPO on 2023-02-10. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical devices and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.

Employees
22
Headquarters
Bellevue, Washington
Listed
Feb 10, 2023
Sector
Health Care
Industry
Biotechnology
Website
osr-holdings.com

OSRH key statistics

Market cap
7.37M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
29.56M
Volume
123.16K
Open price
$0.195
High today
$0.21
Low today
$0.1925
52 Week high
$1.24
52 Week low
$0.242

OSR Holdings (OSRH) at a glance

As of Oct 20, 2026, OSR Holdings (OSRH) shares are priced at $0.2099, giving the company a market cap of 7.37M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.1925 and $0.21. The current price is 9.0% above the day's low and 0.0% below its high.

Volume so far is 123.16K shares, below the average of 29.56M shares a day.

Over the past year OSR Holdings has ranged from $0.242 to $1.24, and now sits -3% of the way up that range.

OSR Holdings met or beat analyst EPS estimates in 1 of the last 2 quarters. In Q4 FY25 it reported -$0.16 per share against an estimate of -$0.102.

OSRH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 2 quarters, by 18.3% on average.

  1. Q3 FY25: reported -$0.10 per share against an estimate of -$0.1224
  2. Q4 FY25: reported -$0.16 per share against an estimate of -$0.102

OSRH news

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

Similar companies

Companies in the same industry as OSR Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.